29 Dec 2012
Dr. TOM WEIDIG is an independent voice in the stuttering community whose blog, The Stuttering Brain, receives more than 100,000 visits a year. Dr. Weidig has volunteered for the British Stammering Association as a former trustee and past chair of its research committee. Tom’s scientific background is in theoretical physics and finance. Dr. Weidig has studied at the University of Cambridge and Imperial College London and was a visiting scholar at Trinity College.
For 2013, Dr. Weidig predicts that basically nothing much will happen in stuttering. Tom states that at this time he views genetic research as the only or main constructive research. Dr. Weidig states that he currently is very cautious and has little hope in pharmaceutical research and deep brain stimulation research. Tom is much more optimistic about current outreach work by self help organizations and those in the stuttering community.
Dr. Weidig discusses his predictions made at the end of 2011 for 2012:
- A Dutch study (or the findings) due out soon will show no difference between Lidcombe treatment for preschoolers and a Demands and Capacities treatment approach.
- More input from mainstream scientists on stuttering research relating to genes and biochemistry.
- More trials on drugs but nothing much happening.
- Discussions on blogs and podcasts might switch more to social media, especially Facebook.
- The results from the large long-term Phase IIb trial on Pagoclone will be released. They will show that the control group (who took a placebo pill) show significant improvements. The study of this effect will force us to reconsider all outcome studies ever done and compare them to the control groups’ improvements.
Tom has been a guest on StutterTalk numerous times. His appearances are archived here.